Cognition Therapeutics, Inc. (CGTX)
CGTX · BiotechSign PipelinePipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Signal Snapshot
2
Clinical Trials (ClinicalTrials.gov aggregate)
0
Catalyst Records
2
Publications on Record
2 Phase 2
Trial Phase Mix
ClinicalTrials.gov aggregate as of 2026-09-29. Source
Recent Publications
- Effect of Donepezil on Speech Recognition in Adult Cochlear Implant Users: A Pilot Randomized Clinical Trial. — Ear Hear (2026) PMID 42776967
- Smartphone-Based Measurement of Cognition and Physical Function in Older Emergency Department Patients: A Feasibility Study. — Acad Emerg Med (2026) PMID 42775945
Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Cognition Therapeutics, Inc..
Full CGTX Data Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.